Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Sydney NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 ASX ANNOUNCEMENT Actinogen September 2026 quarterly activity report and Appendix 4C Sydney, 19 October 2026. Actinogen Medical ASX: ACW (“ACW” or “the...
ACW September 2026 quarterly activity report & Appendix 4C
Filed with ASX · · 9 pages · English
Release
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- Notification of buy-back - ACW
- AGM date and closing date for director nominations
- Application for quotation of securities - ACW
- Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
- Underwriting of unlisted options completed
Later from Actinogen Medical
- ACW pivotal Alzheimers trial database lock - results mid-Nov
- Actinogen receives $10.8m R&D tax incentive rebate from ATO
- Letter to Shareholders, Notice of AGM & Proxy Form
- Response to ASX Price Query
- Update - Notification of buy-back - ACW
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical